Probiosis-5

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

Saccharomyces cerevisiae (Boulardii), Quantity: 5 billion CFU; Lactobacillus gasseri, Quantity: 2 billion CFU; Lactobacillus reuteri, Quantity: 3 billion CFU; Bifidobacterium breve, Quantity: 5 billion CFU; Lactobacillus rhamnosus, Quantity: 5 billion CFU

Commercializzato da:

Spectrumceuticals Pty Ltd

INN (Nome Internazionale):

Bifidobacterium breve,Lactobacillus gasseri,Lactobacillus reuteri,Lactobacillus rhamnosus,Saccharomyces cerevisiae (Boulardii)

Forma farmaceutica:

Capsule, hard

Composizione:

Excipient Ingredients: colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; hypromellose; purified water

Via di somministrazione:

Oral

Indicazioni terapeutiche:

Maintain/support general health and wellbeing ; Maintain/support intestinal health ; Maintain/support intestinal good/beneficial/friendly flora ; Maintain/support small intestine good/beneficial/friendly flora ; Maintain/support gastrointestinal system health ; Maintain/support gastrointestinal mucosal membrane health ; Maintain/support immune system health ; Maintain/support healthy immune system function ; Maintain/support healthy gastrointestinal immune function

Dettagli prodotto:

Visual Identification: ;

Stato dell'autorizzazione:

Licence status A

Data dell'autorizzazione:

2017-09-13